Search results
From Self-sufficiency
- ...Nivorozhkin A, Szabó C | title = Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol | journal =7 KB (864 words) - 15:41, 27 September 2010
- ...in Plasmodium falciparum and the antimalarial activity of crystallization inhibitors.| journal = Parasitol Research | volume = 100 | issue = 4 | pages = 671–616 KB (2,187 words) - 15:41, 27 September 2010
- ...rieve/pii/S030698770500647X Chlorpheniramine, selective serotonin-reuptake inhibitors (SSRIs) and over-the-counter (OTC) treatment.] Medical Hypotheses'', 2006; [[Category:Serotonin-norepinephrine reuptake inhibitors]]6 KB (745 words) - 14:05, 6 July 2010
- ...acists |title=Targeting bacterial virulence: the role of protein synthesis inhibitors in severe infections. Insights from the Society of Infectious Diseases Phar25 KB (3,261 words) - 13:17, 11 September 2010
- ...or = Neu HC, Gootz TD | chapter = Antimicrobial Chemotherapy:Antimicrobial Inhibitors of Ribosome Function | title = Baron's Medical Microbiology |editor=Baron ...of, for example, [[antidepressants]], [[antiepileptics]] and [[proton pump inhibitors]] if they are given concomitantly. Inhibition of CYP3A4 causes increased le29 KB (3,876 words) - 15:42, 27 September 2010
- ...felder SC |title=Treatment of recalcitrant recurrent corneal erosions with inhibitors of matrix metalloproteinase-9, doxycycline and corticosteroids |journal=Am.20 KB (2,578 words) - 15:43, 27 September 2010
- {{Nucleic acid inhibitors}}19 KB (2,528 words) - 15:43, 27 September 2010
- {{Nucleic acid inhibitors}}12 KB (1,576 words) - 15:43, 27 September 2010
- {{Nucleic acid inhibitors}}10 KB (1,346 words) - 15:43, 27 September 2010
- ...p://www.med.sc.edu:96/Biopharm/PDFs/NucleicAcidInhibitors.pdf Nucleic acid inhibitors] (PDF file). [[Category:Dihydrofolate reductase inhibitors]]8 KB (1,056 words) - 19:12, 10 September 2010
- {{Nucleic acid inhibitors}}15 KB (2,087 words) - 15:43, 27 September 2010
- ...pamil]], [[nifedipine]], [[simvastatin]], [[midazolam]] and [[HIV protease inhibitors]]. Other possible interactions include [[antiretroviral agents]], [[everoli {{Nucleic acid inhibitors}}18 KB (2,471 words) - 15:43, 27 September 2010
- ...its translocation during [[protein synthesis]]<ref>Pestka, S.: "The Use of Inhibitors in Studies on Protein Synthesis", Methods in Enzymology 30, pp.261-282, 1974 KB (503 words) - 15:44, 27 September 2010
- ...nosine]] and [[zalcitabine]]. HIV strains that are resistant to [[protease inhibitors]] are not likely to be resistant to abacavir. [[Category:Nucleoside analog reverse transcriptase inhibitors]]8 KB (1,124 words) - 15:44, 27 September 2010
- [[Category:Nucleoside analog reverse transcriptase inhibitors]]9 KB (1,239 words) - 15:44, 27 September 2010
- [[Category:Nucleoside analog reverse transcriptase inhibitors]]5 KB (667 words) - 15:44, 27 September 2010
- ...approval process switched to [[protease inhibitor (pharmacology)|protease inhibitors]]. According to the manufacturer's 2004 annual report, its patent will expi [[Category:Nucleoside analog reverse transcriptase inhibitors]]9 KB (1,248 words) - 15:44, 27 September 2010
- [[Category:Nucleoside analog reverse transcriptase inhibitors]]4 KB (574 words) - 15:44, 27 September 2010
- [[Category:Nucleoside analog reverse transcriptase inhibitors]]6 KB (871 words) - 15:45, 27 September 2010
- ...ase at 2.35-A resolution and the mechanism of resistance to non-nucleoside inhibitors | journal=Proc Natl Acad Sci USA | volume=99 | pages=14410–15 | pmid=1238 ...z lowers blood levels of most [[protease inhibitor (pharmacology)|protease inhibitors]]. Dosages of [[amprenavir]], [[atazanavir]], or [[indinavir]] may need to10 KB (1,441 words) - 15:45, 27 September 2010